Stratification for RRMM and Risk-Adapted Therapy: Sequencing of Therapies in RRMM

SIMPLE SUMMARY: In recent years, many new therapeutic options for newly diagnosed, as well as relapsed and refractory multiple myeloma (MM) have been approved. They have dramatically improved progression-free and overall survival. Despite these advances, MM still remains incurable and eventually all...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeryczynski, Georg, Bolomsky, Arnold, Agis, Hermine, Krauth, Maria-Theresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657274/
https://www.ncbi.nlm.nih.gov/pubmed/34885001
http://dx.doi.org/10.3390/cancers13235886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657274/
https://www.ncbi.nlm.nih.gov/pubmed/34885001
http://dx.doi.org/10.3390/cancers13235886

Ejemplares similares